Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RET | P07949 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 5/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2940189 | 0.82 | POLB (0.44) | POLBALDH1A1SMN1; SMN2TDP1LMNA | |
| SCHEMBL2934277 | 0.79 | POLB (0.44) | POLBALDH1A1SMN1; SMN2TDP1LMNA | |
| SCHEMBL11500090 | 0.79 | POLB (0.41) | POLBALDH1A1SMN1; SMN2TDP1LMNA | |
| SCHEMBL11853875 | 0.78 | POLB (0.33) | POLBALDH1A1ALOX5TSHRCYP3A4 | |
| SCHEMBL2937582 | 0.76 | RET (0.37) | ALDH1A1SMN1; SMN2TDP1LMNARET | |
| SCHEMBL27495127 | 0.75 | TSHR (0.35) | ALDH1A1TDP1LMNAHPGDTSHR | |
| SCHEMBL24596048 | 0.75 | POLB (0.46) | POLBALDH1A1SMN1; SMN2LMNAALOX5 | |
| SCHEMBL27463614 | 0.74 | TSHR (0.35) | ALDH1A1TDP1LMNAHPGDTSHR | |
| SCHEMBL27461817 | 0.74 | TSHR (0.35) | ALDH1A1TDP1LMNAHPGDTSHR | |
| SCHEMBL27357700 | 0.73 | POLB (0.45) | POLBALDH1A1HPGDRETCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1756027-B1 | PROCESS FOR PRODUCING INDENOL ESTERS OR ETHERS | FIRMENICH & CIE (CH) | 2010-09-22 | — | — | EP | disclosed |
| US-7250528-B2 | Process for producing indenol esters or ethers | FIRMENICH SA (CH) | 2007-07-31 | — | — | US | disclosed |
| EP-1756027-A2 | PROCESS FOR PRODUCING INDENOL ESTERS OR ETHERS | FIRMENICH SA (CH) | 2007-02-28 | — | — | EP | disclosed |
| US-20070032402-A1 | Process for producing indenol esters or ethers | FIRMENICH SA (CH) | 2007-02-08 | — | — | US | disclosed |
| WO-2005113473-A2 | PROCESS FOR PRODUCING INDENOL ESTERS OR ETHERS | FIRMENICH SA (CH) | 2005-12-01 | — | — | WO | disclosed |
| US-20050261513-A1 | Process for producing indenol esters or ethers | FIRMENICH SA (CH) | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032402-A1 | Process for producing indenol esters or ethers | NISCH, SULT2A1, SI | POLB 4549/4885ALDH1A1 120/4885SMN1; SMN2 4330/4885 |
| US-20050261513-A1 | Process for producing indenol esters or ethers | NISCH, SI, SULT2A1 | POLB 4506/4885ALDH1A1 95/4885SMN1; SMN2 4311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.